Literature DB >> 25835418

Variants in Antiviral Genes are Risk Factors for Cognitive Decline and Dementia.

Federico Licastro, Elena Raschi, Ilaria Carbone, Elisa Porcellini.   

Abstract

A gene association study of factors regulating antiviral response such as interferon (IFN)-λ3, also known as IL-28B, mediator complex (Med) 23, and interferon regulatory factor (IRF) 7 with cognitive deterioration and Alzheimer's disease (AD) was performed. Differences in the TT genotype distribution of IL-28B single nucleotide polymorphism (SNP) between AD patients and controls were found. The GG genotype of Med23 gene appeared to influence the progression of the disease, being more frequent in the APOE ɛ4 negative elderly that developed AD during the five year follow-up. Leukocyte positivity for Epstein Barr virus (EBV) and human herpes virus (HHV)-6 DNA was analyzed. Med23 GG genotype correlated with the positivity to HHV-6 DNA. EBV and HHV-6 plasma IgG levels were also investigated and EBV IgG levels were increased in AD with the IRF7 GG genotype. A differential genetic background in genes regulating anti-virus responses was associated with an increased risk of cognitive decline and AD. EBV and HHV-6 appeared to be risk factors for AD in genetically susceptible elderly.

Entities:  

Keywords:  Alzheimer’s disease; antiviral genes; case-control study; gene polymorphisms; herpes virus infection

Mesh:

Substances:

Year:  2015        PMID: 25835418     DOI: 10.3233/JAD-142718

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

Review 1.  The Role of Human Herpesvirus 6 Infection in Alzheimer's Disease Pathogenicity-A Theoretical Mosaic.

Authors:  Constantin Romanescu; Thomas Gabriel Schreiner; Ilya Mukovozov
Journal:  J Clin Med       Date:  2022-05-29       Impact factor: 4.964

Review 2.  Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease.

Authors:  Juliet M Taylor; Zachery Moore; Myles R Minter; Peter J Crack
Journal:  J Neural Transm (Vienna)       Date:  2017-07-04       Impact factor: 3.575

Review 3.  Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease.

Authors:  Tamas Fulop; Shreyansh Tripathi; Serafim Rodrigues; Mathieu Desroches; Ton Bunt; Arnold Eiser; Francois Bernier; Pascale B Beauregard; Annelise E Barron; Abdelouahed Khalil; Adam Plotka; Katsuiku Hirokawa; Anis Larbi; Christian Bocti; Benoit Laurent; Eric H Frost; Jacek M Witkowski
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-04       Impact factor: 2.570

4.  Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer's Disease.

Authors:  Francesca La Rosa; Marina Saresella; Francesca Baglio; Federica Piancone; Ivana Marventano; Elena Calabrese; Raffaello Nemni; Enrico Ripamonti; Monia Cabinio; Mario Clerici
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

5.  Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte.

Authors:  Qing Shao; Zhe Lin; Xiaohui Wu; Junwei Tang; Shuai Lu; Dongju Feng; Ci Cheng; Lanqun Qing; Kun Yao; Yun Chen
Journal:  Oncotarget       Date:  2016-07-26

Review 6.  Role of Microbes in the Development of Alzheimer's Disease: State of the Art - An International Symposium Presented at the 2017 IAGG Congress in San Francisco.

Authors:  Tamàs Fülöp; Ruth F Itzhaki; Brian J Balin; Judith Miklossy; Annelise E Barron
Journal:  Front Genet       Date:  2018-09-10       Impact factor: 4.599

7.  Impaired Innate Immunity Mechanisms in the Brain of Alzheimer's Disease.

Authors:  Martina Romagnoli; Elisa Porcellini; Ilaria Carbone; Robert Veerhuis; Federico Licastro
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.